DOCSLIB.ORG

Skin Cancer Crash Course

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Skin Cancer Crash Course Skin Cancer Crash Course: Recognition and Management of Nonmelanoma Skin Cancer Victor Neel, MD, PhD Director, Dermatologic Surgery, MGH Disclosures Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. Blood Vessels sebaceous Pyogenic granuloma glomus tumor neural sebaceous carcinoma Kaposi’s sarcoma Angiosacoma sebaceous adenoma Neurofibroma Epitheliod hemangioendothelioma Masson tumor sebaceoma Neurothekeoma Targetoid hemosiderotic hemangioma Angiokeratoma Schwannoma immune cell Glomangioma AV hemangioma Palisaded encapsulated neuroma Lymphoma Merkel cell carcinoma Mast cell disease histiocytosis epithelial actinic keratosis squamous cell carcinoma eccrine keratoacanthoma seborrheic keratosis Microcystic adnexal ca porokeratosis Mucinous eccrine carcinoma Eccrine spriradenoma fibroblasts Cylindroma follicular Atypical fibroxanthoma Basal cell carcinoma Poroma Malignant fibrous histiocytoma Trichoepithelioma Porocarcinoma Pilar sheath acanthoma Nodular hidradenoma fat smooth muscle Tricholemmoma Syringoma Lipoma Leiomyoma Trichofolliculoma Chondroid syringoma angiolipoma Leiomyosarcoma Pilomatricoma Digital papillary adenocarcinoma Spindle cell lipoma angioleiomyoma Trichoblastoma Extramammarary Paget’s liposarcoma Fibrofolliculoma pleomorphic lipoma metastatic Desmoplastic trichoepithelioma Goals of This Talk • Discuss the most common NMSC tumors you will see and possibly diagnose & treat • Convince you to consider performing skin biopsies in your practice Primary Care & Dermatology • Too many patients, too many tumors • Delayed diagnosis, delayed treatment • Many skin cancers can be diagnosed and treated in primary care setting • PCPs must definitively diagnosis and have treatment algorithms in place US Skin Cancer Incidence • >5 million new cases of NMSC each year • BCC about 80%, SCC about 20% • About 15,000 deaths per year from SCC, more than twice as many than melanoma Causes of Nonmelanoma Skin Cancer • Chronic UV exposure –> genetic mutations • Immunosuppression – Organ transplant patients and CLL patients – 80% of transplant patients develop skin cancers – 200-fold increased risk of SCC • Human papillomavirus - HPV 6,16 (vaccine may affect) • Inherited diseases - XP, BCNS, albinism Basal Cell Carcinoma Stats • most common cancer in humans • 3 million new cases a year, increasing 5% per year • 1/3 of all Caucasians will develop at least one lesion • billions of healthcare $$ spent Basal Cell Carcinoma Biology • very indolent growth – perhaps decades until clinically apparent • rarely metastatic (<0.01%) but very lethal – usually in neglected or multiply-recurrent tumors – locally destructive (cosmetically devastating) • >75% most sporadic tumors have defects in Sonic hedgehog signaling pathway (oral drug, vismodegib, topicals in develpoment) Which Is BCC? Basal Cell Carcinoma • Subtypes – Nodulo-ulcerative (most common) – Morpheaform (sclerosing, infiltrative) – Micronodular – Metatypical (basosquamous) – Superficial (“multicentric”) Basal Cell Carcinoma • Subtypes – Nodulo-ulcerative (most common) Basal Cell Carcinoma • Pigmented BCC • Can mimic MM Basal Cell Carcinoma • Subtypes – Morpheaform BCC – Can look like scar Basal Cell Carcinoma • Subtypes – Superficial “multicentric” – Can be misdiagnosed as psoriasis, tinea or eczema – Most common type on trunk and extremities BCC or Tinea? Tinea BCC itchy & scaly crusts/bleeds often multiple usually single antifungals sun-exposed BCCs? Basal Cell Carcinoma • Course – Slow, progressive growth – Bleeding, ulceration, superinfection – Enlarges over months to years – Is capable of extensive tissue destruction (invading into muscle, cartilage, and bone) Suspected lesion Differential ?biopsy Treatment diagnosis ?refer options Actinic keratosis SK, wart, porokeratosis, NO 5-FU, imiquimod, trichilemmoma NO cryotherapy, PDT-ALA Squamous cell AK, discoid lupus, tinea YES 5-FU, imiquimod, PDT-ALA, carcinoma, in situ psoriasis, SK YES cryotherapy, curettage surgery Squamous cell SK, AK, BCC, pyoderma YES surgery, Mohs surgery, carcinoma, invasive gangrenosum YES radiation (rarely) BCC, superficial tinea, SCC in situ, discoid lupus, ? 5-FU, imiquimod, (body) porokeratosis, SCC in situ ? cryotherapy, curettage, surgery BCC, nodular nevus (melanocytic), molluscum YES cryo, curettage, surgery (body) YES BCC, infiltrative or scar YES recurrent (body) YES BCC, any type nevus, rosacea, angiofibroma, YES Mohs surgery (head & neck) syringoma, sebaceous YES hyperplasia, tinea, discoid lupus, SCC, trichoepithelioma, telangiectasia, scar Squamous Cell Carcinoma • Second most common skin cancer in the general population • Most common skin cancer in transplant recipients • Appears on sun-exposed skin • Red, scaly, firm, may ulcerate • 1-15% metastasize (lip & ear) Squamous Cell Carcinoma • Arises primarily on sun-damaged skin – Precursor is actinic keratosis (AK) on sun-exposed sites – 90% of AKs spontaneously resolve • May occur anywhere on skin • Face • Lips (usually lower) • Ears • Dorsal hands • Chest Diffuse AKs? 5-FU!! Two Weeks of Topical 5-FU Squamous Cell Carcinoma • Metastasis more likely in: – Recurrent tumors – Those with diameter > 2 cm – Those with depth > 6 mm – Mucosal sites, periauricular skin (lip & ear) – SCC arising from chronic wounds (Marjolin’s ulcer) – Perineural invasion of larger nerve fibers – Immunocompromised patients Squamous Cell Carcinoma • Subtypes – Keratoacanthoma • Rapid initial growth • May be painful (unlike most NMSCs) • Exophytic nodule with central keratin-filled crater • Remains stable for a few months • May spontaneously resolve – new research!! • Dermpath reports as well-differentiated SCC Time to get the derm surgeon on the phone Squamous Cell Carcinoma • Subtypes – Bowen’s Disease • Squamous cell carcinoma in situ • Thin, erythematous, scaling plaques • Can progress into, and/or coincide with invasive SCC • Can be misdiagnosed as psoriasis, tinea, eczema or BCC Incidence Ratios of Skin Cancer in Transplant Recipients • Squamous cell 100-fold increase carcinoma • Basal cell carcinoma 10-fold increase • Melanoma 3.4-fold increase Mortality from Metastatic Skin Cancer in Transplant Patients Country Organ Cancer Mortality Rate type Australia Kidney SCC 5% of all patients with SCC New Zealand Australia Heart All 27% total deaths occurring after the 4th yr post transplant USA All SCC 3 yr cause specific survival 54%, n = 71 USA All Melanoma 30% (compared to 15% in general population) A Lethal Tumor in a Transplant Patient Please have your transplant patients see a dermatologist for baseline evaluation Surgical Emergencies in Dermatology • SCC in immunosuppressed population – Iatrogenic (organ transplant, anti-inflammatory states) – CLL or other leukemias/marrow failures AML – 80% blast, 0%PMNs Suspected lesion Differential ?biopsy Treatment diagnosis ?refer options Actinic keratosis SK, wart, porokeratosis, NO 5-FU, imiquimod, trichilemmoma NO cryotherapy, PDT-ALA Squamous cell AK, discoid lupus, tinea YES 5-FU, imiquimod, PDT- carcinoma, in situ psoriasis, SK YES ALA, cryotherapy, curettage surgery Squamous cell SK, AK, BCC, pyoderma YES surgery, Mohs surgery, carcinoma, invasive gangrenosum YES radiation (rarely) BCC, superficial tinea, SCC in situ, discoid lupus, ? 5-FU, cryotherapy. (body) porokeratosis, ? curettage, surgery BCC, nodular nevus (melanocytic), YES cryo, curettage, surgery (body) molluscum YES BCC, infiltrative or scar YES recurrent (body) YES BCC, any type nevus, rosacea, angiofibroma, YES Mohs surgery (head & neck) syringoma, sebaceous YES hyperplasia, tinea, discoid lupus, SCC, trichoepithelioma, telangiectasia, scar Less Common Tumors DFSP Dermatofibroma Extramammary Paget’s Extramammary Paget’s A Challenge to Primary Care: DO YOUR OWN BIOPSIES! Primary Care & Dermatology Delay in Diagnosis & Treatment • Community dermatology shortage: 2-6 months • Community surgical dermatology shortage (Mohs surgery): 1-3 months Typical delay from Primary care to definitive treatment: 3-9 months!!! Essentials for Serious PCPs Do a “real” skin exam Document lesions and take a pre-biopsy photo & measurement Do not be afraid to biopsy early – low-risk of complications If the biopsy is inadequate or doesn’t fit the clinical picture, re-biopsy! Essentials for Serious PCPs • Don’t worry if your biopsies come back with benign diagnoses – steep learning curve • If you treat a lesion, see the patient back to confirm improvement. If not improving biopsy or refer, DON’T KEEP TREATING!! This Is Not an Actinic Keratosis! In-Office Biopsy Cost: $1.50 Time: 5-10 minutes. CLEAN not STERILE prep Reimbursement: $60-100 (CPT 11102) sterile #15 blade clean gauze & Q-tips 3cc lido/epi bottle Drysol in room vaseline & plaster obtain signed consent Biopsy Video Please refer biopsy-proven skin cancers to dermatologic surgery, not plastics Nicotinamide for Prevention • Nicotinamide (vitamin B3) 500mg BID • ~25% reduction of SCC/BCC in high risk skin cancer patients at 1 yr • low side effect profile • (NOT NIACIN) The dermatologist will see you! [email protected].
Load more

Recommended publications
  • Glossary for Narrative Writing
    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
    [Show full text]
  • Skin and Breast Disease in the Differential Diagnosis of Chest Pain
    Skin and breast disease in the differential diagnosis of chest pain Author Muir, Jim, Yelland, Michael Published 2010 Journal Title Medical Clinics of North America DOI https://doi.org/10.1016/j.mcna.2010.01.006 Copyright Statement © 2010 Elsevier. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. Downloaded from http://hdl.handle.net/10072/33712 Griffith Research Online https://research-repository.griffith.edu.au ARTICLE IN PRESS 1 2 Skin and Breast 3 4 Disease in the 5 6 Differential 7 8 Diagnosis of 9 10 Chest Pain 11 12 a, b ½Q2½ Q3 Jim Muir *, Michael Yelland ½Q4½ Q5 KEYWORDS 13 14 Chest pain Skin diseases Herpes zoster PROOF 15 Breast Neoplasm 16 17 18 Pain is not a symptom commonly associated with skin disease. This is especially so 19 when considering the known skin problems that have a presenting symptom of chest 20 pain that could potentially be confused with chest pain from other causes. 21 22 PAINFUL SKIN CONDITIONS 23 24 Several extremely painful and tender skin conditions present with dramatic clinical 25 signs. Inflammatory disorders such as pyoderma gangrenosum, skin malignancies, 26 both primary and secondary, acute bacterial infections such as erysipelas or cellulitis, 27 and multiple other infections are commonly extremely painful and tender. As these 28 conditions manifest with obvious skin signs such as swelling, erythema, localized 29 tenderness, fever, lymphangitis, and lymphadenopathy, there is little chance of misdi- 30 agnosis of symptoms as caused by anything other than a cutaneous pathology.
    [Show full text]
  • Benign Tumors and Tumor-Like Lesions of the Vulva
    Please do not remove this page Benign Tumors and Tumor-like Lesions of the Vulva Heller, Debra https://scholarship.libraries.rutgers.edu/discovery/delivery/01RUT_INST:ResearchRepository/12643402930004646?l#13643525330004646 Heller, D. (2015). Benign Tumors and Tumor-like Lesions of the Vulva. In Clinical Obstetrics & Gynecology (Vol. 58, Issue 3, pp. 526–535). Rutgers University. https://doi.org/10.7282/T3RN3B2N This work is protected by copyright. You are free to use this resource, with proper attribution, for research and educational purposes. Other uses, such as reproduction or publication, may require the permission of the copyright holder. Downloaded On 2021/09/23 14:56:57 -0400 Heller DS Benign Tumors and Tumor-like lesions of the Vulva Debra S. Heller, MD From the Department of Pathology & Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, NJ Address Correspondence to: Debra S. Heller, MD Dept of Pathology-UH/E158 Rutgers-New Jersey Medical School 185 South Orange Ave Newark, NJ, 07103 Tel 973-972-0751 Fax 973-972-5724 [email protected] Funding: None Disclosures: None 1 Heller DS Abstract: A variety of mass lesions may affect the vulva. These may be non-neoplastic, or represent benign or malignant neoplasms. A review of benign mass lesions and neoplasms of the vulva is presented. Key words: Vulvar neoplasms, vulvar diseases, vulva 2 Heller DS Introduction: A variety of mass lesions may affect the vulva. These may be non-neoplastic, or represent benign or malignant neoplasms. Often an excision is required for both diagnosis and therapy. A review of the more commonly encountered non-neoplastic mass lesions and benign neoplasms of the vulva is presented.
    [Show full text]
  • Angiokeratoma of the Scrotum (Fordyce Type) Associated with Angiokeratoma of the Oral Cavity
    208 Letters to the Editor anti-thyroperoxidas e antibody in addition to, or, less Yamada A. Antineutrophil cytoplasmic autoantibody- likely, instead of MPO-ANCA cannot be excluded. positive crescentric glomerulonephritis associated with thi- amazole therapy. Nephron 1996; 74: 734–735. Vesiculo-bullous SLE has been reported to respond 6. Cooper D. Antithyroid drugs. N Engl J Med 1984; 311: to dapsone (15). However, in our patient, an early 1353–1362. aggressive treatment with steroid pulse therapy and 7. Yung RL, Richardson BC. Drug-induced lupus. Rheum plasmapheresis was mandatory because of her life- Dis Clin North Am 1994; 20: 61–86. threatening clinical condition. The contributory factors, 8. Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460–1462. such as an environmental trigger or an immunological 9. Sato-Matsumura KC, Koizumi H, Matsumura T, factor, for the presence of a serious illness in this patient Takahashi T, Adachi K, Ohkawara A. Lupus eryth- remain to be elucidated. The mechanism by which ematosus-like syndrome induced by thiamazole and methimazole induces SLE-like reactions is unclear. propylthiouracil. J Dermatol 1994; 21: 501–507. 10. Wing SS, Fantus IG. Adverse immunologic eVects of antithyroid drugs. Can Med Assoc J 1987; 136: 121–127. 11. Condon C, Phelan M, Lyons JF. Penicillamine-induced REFERENCES type II bullous systemic lupus erythematosus. Br J Dermatol 1997; 136: 474–475. 1. Alarcon-Segovia D. Drug induced lupus syndromes. Mayo 12. Stankus S, Johnson N. Propylthiouracil-induced hyper- Clin Proc 1969; 44: 664–681.2. sensitivity vasculitis presenting as respiratory failure. Chest 2. Cush JJ, Goldings EA.
    [Show full text]
  • A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated Through 445 Nm Diode Laser
    healthcare Case Report A Single Case Report of Granular Cell Tumor of the Tongue Successfully Treated through 445 nm Diode Laser Maria Vittoria Viani 1,*, Luigi Corcione 1, Chiara Di Blasio 2, Ronell Bologna-Molina 3 , Paolo Vescovi 1 and Marco Meleti 1 1 Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy; [email protected] (L.C.); [email protected] (P.V.); [email protected] (M.M.) 2 Private practice, Centro Medico Di Blasio, 43121 Parma; Italy; [email protected] 3 Faculty of Dentistry, University of the Republic, 14600 Montevideo, Uruguay; [email protected] * Correspondence: [email protected] Received: 10 June 2020; Accepted: 11 August 2020; Published: 13 August 2020 Abstract: Oral granular cell tumor (GCT) is a relatively rare, benign lesion that can easily be misdiagnosed. Particularly, the presence of pseudoepitheliomatous hyperplasia might, in some cases, lead to the hypothesis of squamous cell carcinoma. Surgical excision is the treatment of choice. Recurrence has been reported in up to 15% of cases treated with conventional surgery. Here, we reported a case of GCT of the tongue in a young female patient, which was successfully treated through 445 nm diode laser excision. Laser surgery might reduce bleeding and postoperative pain and may be associated with more rapid healing. Particularly, the vaporization effect on remnant tissues could eliminate GCT cells on the surgical bed, thus hypothetically leading to a lower rate of recurrence. In the present case, complete healing occurred in 1 week, and no recurrence was observed after 6 months. Laser surgery also allows the possibility to obtain second intention healing.
    [Show full text]
  • Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
    4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al.
    [Show full text]
  • Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
    16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma .
    [Show full text]
  • The Health-Related Quality of Life of Sarcoma Patients and Survivors In
    Cancers 2020, 12 S1 of S7 Supplementary Materials The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of A Nationwide Observational Study (PROSa) Martin Eichler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Jens Jakob, Susanne Singer, Robert Grützmann, Stephen Fung, Eva Wardelmann, Karin Arndt, Vitali Heidt, Christine Hofbauer, Marius Fried, Verena I. Gaidzik, Karl Verpoort, Marit Ahrens, Jürgen Weitz, Klaus-Dieter Schaser, Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler and the PROSa study group Includes Entities We included sarcomas according to the following WHO classification. - Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 p. (World Health Organization classification of tumours). - Kurman RJ, International Agency for Research on Cancer, World Health Organization, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. 307 p. (World Health Organization classification of tumours). - Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106–19. - World Health Organization, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed.
    [Show full text]
  • Appendix 4 WHO Classification of Soft Tissue Tumours17
    S3.02 The histological type and subtype of the tumour must be documented wherever possible. CS3.02a Accepting the limitations of sampling and with the use of diagnostic common sense, tumour type should be assigned according to the WHO system 17, wherever possible. (See Appendix 4 for full list). CS3.02b If precise tumour typing is not possible, generic descriptions to describe the tumour may be useful (eg myxoid, pleomorphic, spindle cell, round cell etc), together with the growth pattern (eg fascicular, sheet-like, storiform etc). (See G3.01). CS3.02c If the reporting pathologist is unfamiliar or lacks confidence with the myriad possible diagnoses, then at this point a decision to send the case away without delay for an expert opinion would be the most sensible option. Referral to the pathologist at the nearest Regional Sarcoma Service would be appropriate in the first instance. Further International Pathology Review may then be obtained by the treating Regional Sarcoma Multidisciplinary Team if required. Adequate review will require submission of full clinical and imaging information as well as histological sections and paraffin block material. Appendix 4 WHO classification of soft tissue tumours17 ADIPOCYTIC TUMOURS Benign Lipoma 8850/0* Lipomatosis 8850/0 Lipomatosis of nerve 8850/0 Lipoblastoma / Lipoblastomatosis 8881/0 Angiolipoma 8861/0 Myolipoma 8890/0 Chondroid lipoma 8862/0 Extrarenal angiomyolipoma 8860/0 Extra-adrenal myelolipoma 8870/0 Spindle cell/ 8857/0 Pleomorphic lipoma 8854/0 Hibernoma 8880/0 Intermediate (locally
    [Show full text]
  • University of Dundee Hidradenoma Masquerading Digital
    CORE Metadata, citation and similar papers at core.ac.uk Provided by University of Dundee Online Publications University of Dundee Hidradenoma masquerading digital ganglion cyst Makaram, Navnit; Chaudhry, Iskander H.; Srinivasan, Makaram S. Published in: Annals of Medicine and Surgery DOI: 10.1016/j.amsu.2016.07.017 Publication date: 2016 Document Version Publisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA): Makaram, N., Chaudhry, I. H., & Srinivasan, M. S. (2016). Hidradenoma masquerading digital ganglion cyst: a rare phenomenon. Annals of Medicine and Surgery , 10, 22-26. DOI: 10.1016/j.amsu.2016.07.017 General rights Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain. • You may freely distribute the URL identifying the publication in the public portal. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 17. Feb. 2017 Annals of Medicine and Surgery 10 (2016) 22e26 Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com Case report Hidradenoma masquerading digital ganglion cyst: A rare phenomenon * Navnit Makaram a, , Iskander H.
    [Show full text]
  • Angiokeratoma of the Scrotum (Fordyce)
    Keio Journal of Medicine Vol. 1, No. 1, January, 1952 ANGIOKERATOMA OF THE SCROTUM (FORDYCE) MASAKATSU IZAKI Department of Dermatology, School of Medicine, Keio University Since Fordyce, in 1896, first described a case of angiokeratoma of the scrotum, many authors have reported and discussed about this dermatosis. However the classification and the nomenclature of this skin disease still remain in a state of confusion. Recently I had a chance to see the report of Robinson and Tasker (1946)(14), discussing the nomenclature of this condition, which held my attention considerably. In this paper I wish to report statistical observation concerning the incidences of this dermatosis among Japanese males, and histopathological studies made in 5 cases of this condition. STATISTICALOBSERVATION It must be first pointed out that this study was made along with the statistical study on angioma senile and same persons were examined in both dermatosis (ref. Studies on Senile Changes in the Skin I. Statistical Observation; Journal of the Keio Medical Society Vol. 28, No. 2, p. 59, 1951). The statistics was handled by the small sampling method. Totals of persons examined were 1552 males. Their ages varied from 16 to 84 years, divided into seven groups: i.e. the late teen-agers (16-20), persons of the third decade (21-30), of the fourth decade (31-40), of the fifth decade (41-50), of the sixth decade (51-60), of the seventh decade (61-70) and a group of persons over 71 years of age. The number of persons and the incidence of this condition in each group are summarized briefly in Table 1.
    [Show full text]
  • Subcutaneous Hemangiosarcoma: the First Report in Maltese Dog
    pISSN 1598-298X / eISSN 2384-0749 J Vet Clin 36(3) : 169-171 (2019) http://dx.doi.org/10.17555/jvc.2019.06.36.3.169 Subcutaneous Hemangiosarcoma: The First Report in Maltese Dog Ha-Jung Kim, Eun-Taek Hong and Guk-Hyun Suh1 Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Korea (Received: March 13, 2019 / Accepted: May 09, 2019) Abstract : Subcutanous hemangiosarcoma is rare malignant condition in dogs. An eleven-year-old neutered male Maltese was presented with multicentric cutaneous hemorrhagic nodules followed by lethargy. The patient showed regenerative anemia and thrombocytopenia with skyrocketing D-dimer, indicating that he had disseminated intravascular coagulation (DIC) on progress. Fine needle aspiration, histopathology, X-ray, and computed tomographic scanning ultimately diagnosed this patient as subcutaneous hemangiosarcoma with disseminated metastasis to the body. Unfortunately, the dog died due to side effects of anti-thrombotic therapy for DIC. This case report described a rare subcutaneous hemangiosarcoma in a Maltese dog. Key words : dog, skin neoplasms, hemangiosarcoma, disseminated intravascular coagulation, histopathology. Introduction had a 2 month history of multicentric cutaneous hemor- rhagic nodules initiated from his dorsum (Fig 1A and C). Hemangiosarcoma (a.k.a. malignant hemangioendotheli- There were no specific findings from skin examination such oma or angisarcoma) is an outbreak of tumor from endothe- as scraping or taping, and no bacteria or fungi were cultured lial cells which occurs more frequently in dogs than any from the lesions. On physical examination, he had a pale other species, accounting for 0.3% to 2.0% of all tumors in mucous membrane with bilateral ocular hemorrhage (Fig dogs with a high fatality rate (1,7).
    [Show full text]